Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSS | P25774 | 6/20 | 0.71 |
| ▸ | CTSK | P43235 | 5/20 | 0.71 |
| ▸ | ACE | P12821 | 1/20 | 0.64 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.63 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.63 |
| ▸ | PPARA | Q07869 | 4/20 | 0.58 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.57 |
| ▸ | CTSL | P07711 | 1/20 | 0.56 |
| ▸ | CTSB | P07858 | 1/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.56 |
| ▸ | PPARG | P37231 | 3/20 | 0.56 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.54 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.54 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.53 |
| ▸ | PPARD | Q03181 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL231980 | 1.00 | CTSS (0.71) | CTSSCTSKACEITGB3ITGA2B | |
| SCHEMBL1310547 | 1.00 | CTSS (0.71) | CTSSCTSKACEITGB3ITGA2B | |
| Benzene SCHEMBL6474758 | 0.99 | CTSS (0.70) | CTSSCTSKACEITGB3ITGA2B | |
| Benzene SCHEMBL3925161 | 0.99 | CTSS (0.70) | CTSSCTSKACEITGB3ITGA2B | |
| SCHEMBL28630396 | 0.95 | CTSS (0.72) | CTSSCTSKACEITGB3ITGA2B | |
| SCHEMBL29824479 | 0.91 | CTSS (0.68) | CTSSCTSKACEITGB3ITGA2B | |
| SCHEMBL28486021 | 0.91 | CTSS (0.61) | CTSSCTSKACEITGB3ITGA2B | |
| SCHEMBL7656189 | 0.91 | PPARA (0.69) | CTSSCTSKACEITGB3ITGA2B | |
| SCHEMBL10380744 | 0.90 | ACE (0.64) | CTSSCTSKACEITGB3ITGA2B | |
| SCHEMBL3270946 | 0.90 | CTSS (0.60) | CTSSCTSKACEITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1137 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122057034-A | Engineering stem cell based on tyrosine-based material encapsulation and construction method and application thereof | 南京工业大学 | 2026-05-19 | — | — | CN | claimed |
| CN-119978100-A | Tizepa Process for producing peptide | 四川吉晟生物医药有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119606958-B | Composition containing pyruvate and preparation method and application thereof | 江苏长泰药业股份有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119930756-A | Preparation method of dual receptor agonist of GIP and GLP-1 | 博瑞生物医药（苏州）股份有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119930788-A | Preparation method of Retatrutide | 四川吉晟生物医药有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119823233-A | Synthesis method of Ruitalutide and Ruitalutide | 杭州思诺达医药科技有限责任公司 | 2025-04-15 | — | — | CN | claimed |
| CN-119708197-A | Ruitalu Process for producing peptide | 深圳翰宇药业股份有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119606958-A | Composition containing pyruvate and preparation method and application thereof | 江苏长泰药业股份有限公司 | 2025-03-14 | — | — | CN | claimed |
| CN-119529056-A | Solid phase preparation method of telipopeptide | 福建基诺厚普生物科技有限公司 | 2025-02-28 | — | — | CN | claimed |
| CN-119431505-A | Freshwater fish protein antihypertensive peptide based on ethylation modification and preparation method thereof | 湖北省农业科学院农产品加工与核农技术研究所 | 2025-02-14 | — | — | CN | claimed |
| EP-1636340-A2 | UNNATURAL REACTIVE AMINO ACID GENETIC CODE ADDITIONS | The Scripps Research Institute (US) | 2006-03-22 | — | — | EP | claimed |
| US-6951946-B2 | Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates | LEXICON PHARMACEUTICALS, INC. (US) | 2005-10-04 | — | — | US | claimed |
| US-20050154211-A1 | Large scale synthesis of 1,2,4- and 1,3,4- oxadiazole carboxylates | KOLB HARTMUTH C (US) | 2005-07-14 | — | — | US | claimed |
| WO-2005003294-A2 | UNNATURAL REACTIVE AMINO ACID GENETIC CODE ADDITIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2005-01-13 | — | — | WO | claimed |
| US-20040265952-A1 | protein containing a modified amino acid that carries an azido or alkynyl group for conjugation to a second molecule such as polymer, label or drug that carries an alkynyl or azido group; translation biochemistry in eukaryotic cells; gene expression inhibitors | THE SCRIPPS RESEARCH INSTITUTE (US) | 2004-12-30 | — | — | US | claimed |
| US-20040019215-A1 | Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates | LEXICON PHARMACEUTICALS, INC. | 2004-01-29 | — | — | US | claimed |
| EP-0584552-B1 | Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them | YEDA RES & DEV (IL) | 2000-10-11 | — | — | EP | claimed |
| US-6031127-A | Process for preparing L-p-boronophenylalanine and intermediate for preparing the same | TOHOKU UNIVERSITY (JP) | 2000-02-29 | — | — | US | claimed |
| US-5767158-A | FOR BLEACHING SKIN | SHISEIDO CO., LTD. (JP) | 1998-06-16 | — | — | US | claimed |
| EP-0049500-B1 | TYROSINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE IN THE SYNTHESIS OF PEPTIDES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1984-02-22 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154211-A1 | Large scale synthesis of 1,2,4- and 1,3,4- oxadiazole carboxylates | OXA1L, ODC1, CYP4B1 | CTSS 2627/4885CTSK 2356/4885ACE 1014/4885 |
| US-20040019215-A1 | Large scale synthesis of 1,2,4- and 1,3,4-oxadiazole carboxylates | OXA1L, ODC1, CYP4B1 | CTSS 2627/4885CTSK 2356/4885ACE 1014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.